Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Clinical TransplantationOpen Access

Early outcomes associated with de novo once‐daily extended‐release versus twice‐daily immediate‐release tacrolimus in a predominantly African American kidney transplant population: A single‐center observational study

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMargaret M. RomineDLDavid B. LeeserKKKaren Kennamer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Romine et al. (2024) studied this question.

synapsesocial.com/papers/68e76825b6db6435876dd87ehttps://doi.org/10.1111/ctr.15268
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early Conversion to Once-Daily MeltDose® Extended-Release Tacrolimus (LCPT) in Liver Transplant Patients2025
  2. 2#2084 Biologic effect evaluation of de novo long-term release tacrolimus on metabolizer phenotype and T cell composition after kidney transplantation2024
  3. 3Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant2024 · 1 citations
  4. 4Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study2024 · 15 citations
  5. 5Dosing, Safety, and Tolerability of Extended‐Release Tacrolimus in Pediatric and Young Adult Solid Organ Transplant Recipients2026